Adjuvant radiotherapy in stage I-II epithelial ovarian cancer

European Journal of Gynaecological Oncology

Volumn 22, Issue 6, 2001, Pages 409-416

  Skirnisdottir I ^a   Sorbe, B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adjuvant therapy; Early stages; Ovarian cancer; Prognosis; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; METASTASIS; OVARY CARCINOMA; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; SURVIVAL RATE; TREATMENT OUTCOME;

FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 0035716151     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Management of early-stage epithelial ovarian cancer
2. Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma
3. Management of early-stage epithelial ovarian cancer
4. Age-specific differences in treatment and survival of ovarian cancer patients in the province of Limburg, the Netherlands 1986-92
5. Molekulargenetik der epithelialen ovarialneoplasien: Korrelationen zum phänotyp und biologischen verhalten
6. Analysis of failures in patients with stage I ovarian cancer: An Italian multicenter study
7. The yield of surgical staging in presumed early stage ovarian cancer: Benefits or doubts?
8. Cancer of the ovary
9. Early ovarian cancer: Is there a role for systematic pelvic and para-aortic lymphadenectomy?
10. Postoperative therapie des epithelialen ovarialkarzinoms
11. Mesenteric and mesocolic lymph node metastases from ovarian carcinoma: A clinicopathological analysis
12. Current controversies in cancer: Is abdomino-pelvic radiation therapy the optimal treatment for completely resected stage I and II high risk ovarian cancer?
13. Adjuvant radiotherapy in early stage ovarian carcinoma
14. Epithelial ovarian cancer: An open question
15. External beam radiotherapy in the management of ovarian carcinoma
16. Carcinoma of the ovary
17. Is there a place for whole abdominal radiotherapy in the management of ovarian cancer?
18. Abdominopelvic radiotherapy in ovarian cancer (A 10-year experience)
19. The Princess Margaret Hospital study of ovarian cancer: Stages I, II and asymptomatic III presentations
20. The evaluation of postoperative irradiation in patients with early-stage ovarian cancer
21. Epithelial ovarian cancer: The role of radiotherapy
22. Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer
23. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma
24. Prognostic factors in patients with stage I epithelial ovarian cancer
25. Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma
26. The accuracy of staging: An important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis
27. DNA ploidy and MYC DNA amplification in ovarian carcinomas
28. Dose-response relatioship for radiation therapy of subclinical disease
29. Controversial issues in the management of early epithelial ovarian cancer: Conservative surgery and role of adjuvant therapy
30. 32P) in women with early ovarian carcinoma after comprehensive surgical staging
31. Randomized trial comparing cisplatin with radioactive phosphorous or whole-abdomen irradiation as adjuvant treatment of ovarian cancer
32. Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary
33. A phase II study of intraperitoneal carboplatin as adjuvant treatment in early stage ovarian cancer patients
34. Multimodal therapy of early-stage (FIGO I-II) ovarian cancer: Review of surgical management and postoperative adjuvant treatment
35. Adjuvant therapy in stage I and II epithelial ovarian cancer. Results of two prospective randomized trials
36. Ovarian carcinoma: Improved survival following abdominopelvic irradiation in patients with a completed pelvic operation